Literature DB >> 30895498

LncRNA NRON alleviates atrial fibrosis via promoting NFATc3 phosphorylation.

Yapeng Wang1, Peng Xu2, Chengxin Zhang3, Junbo Feng3, Wenhui Gong3, Shenglin Ge4, Zhixiang Guo5.   

Abstract

The aim of this study was to explore the role of NRON in the atrial fibrosis. The expression of NRON in atrial tissue was detected using qRT-PCR. The protein levels of collagen I, collagen III, NFATc3 and p-NFATc3 were determined by western blot. Immunohistochemistry assay were performed to observe expression and distribution of collagen I in atrial tissues. The atrial fibroblasts were authenticated by vimentin/troponin immunofluorescence staining. Fibroblast proliferation was detected by CCK-8 assay. The morphological changes of cardiac tissue were observed by HE staining. Myocardial fibrosis was detected by masson staining. NRON expression was significantly downregulated in atrial tissues of AF. NRON suppressed fibroblast proliferation; expression of collagen I and collagen III; activation of NFATc3 and nucleu import. NRON promoted p-NFATc3 expression and alleviated atrial fibrosis in vivo. Our data indicated that NRON alleviates atrial fibrosis via promoting NFATc3 phosphorylation.

Entities:  

Keywords:  Atrial fibrosis; NFATc3 phosphorylation; NRON

Mesh:

Substances:

Year:  2019        PMID: 30895498     DOI: 10.1007/s11010-019-03521-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  6 in total

1.  The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart.

Authors:  Jeannine Hoepfner; Julia Leonardy; Dongchao Lu; Kevin Schmidt; Hannah J Hunkler; Sinje Biß; Ariana Foinquinos; Ke Xiao; Kumarswamy Regalla; Deepak Ramanujam; Stefan Engelhardt; Christian Bär; Thomas Thum
Journal:  Mol Ther       Date:  2021-11-29       Impact factor: 11.454

2.  Long noncoding RNA SNHG3 promotes malignant phenotypes in cervical cancer cells via association with YAP1.

Authors:  Hongyu Zhu; Chenyu Zhu; Xiang Feng; Youzhen Luo
Journal:  Hum Cell       Date:  2021-11-24       Impact factor: 4.174

Review 3.  Research Progress of LncRNAs in Atrial Fibrillation.

Authors:  Wenhui Wang; Bei Tian; Zhongping Ning; Xinming Li
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.695

4.  miR‑101a‑3p overexpression prevents acetylcholine‑CaCl2‑induced atrial fibrillation in rats via reduction of atrial tissue fibrosis, involving inhibition of EZH2.

Authors:  Jing Zhu; Ning Zhu; Jian Xu
Journal:  Mol Med Rep       Date:  2021-08-26       Impact factor: 2.952

5.  LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.

Authors:  Tiefu Xiong; Chenchen Huang; Jianfa Li; Shaokang Yu; Fangfang Chen; Zeng Zhang; Chengle Zhuang; Yawen Li; Changshui Zhuang; Xinbo Huang; Jing Ye; Fangting Zhang; Yaoting Gui
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

6.  LncRNA Nuclear-Enriched Abundant Transcript 1 Regulates Atrial Fibrosis via the miR-320/NPAS2 Axis in Atrial Fibrillation.

Authors:  Huangdong Dai; Naishi Zhao; Hua Liu; Yue Zheng; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.